Effect of recombinant human TNF on human ovarian cancer cell lines.

A. Vigani, L. Miglietta, S. Chiara, L. Repetto, E. Pichi, G. Cimoli, L. Morelli, L. Poggi, G. Billi, S. Parodi

Research output: Contribution to journalArticle

Abstract

Ovarian cancer is the second most common gynecologic malignancy. Standard therapeutic approaches to this disease, surgery followed by chemotherapy, have produced response rates of up to 80%. However, the five-year survival rate remains around 30%. Recently, Tumor Necrosis Factor (TNF) has received attention as either an alternative or an associated agent for chemotherapy of ovarian cancer. TNF is known to have direct cytotoxic and cytostatic effects on a variety of transformed cell lines "in vitro". Furthermore, TNF is known to enhance significantly the "in vitro" effects of a class of chemotherapeutic agents, specifically those targeted at DNA topoisomerase II. In this work we have investigated TNF-induced cytotoxicity in four established human epithelial ovarian cancer cell lines: A-2774; SV-626; SKOV-3 and Pa-1. TNF mediated cytotoxic activity was observed in a range of concentrations between 1 U/ml and 10-3 U/ml. A-2774 and SV-626 were the two most sensitive lines, especially when exposed to high concentrations of TNF.

Original languageEnglish
Pages (from-to)537-542
Number of pages6
JournalBollettino della Societa Italiana di Biologia Sperimentale
Volume66
Issue number6
Publication statusPublished - Jun 1990

Fingerprint

Ovarian Neoplasms
Tumor Necrosis Factor-alpha
Cell Line
Drug Therapy
Type II DNA Topoisomerase
Transformed Cell Line
Cytostatic Agents
human TNF protein
Neoplasms
In Vitro Techniques

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Vigani, A., Miglietta, L., Chiara, S., Repetto, L., Pichi, E., Cimoli, G., ... Parodi, S. (1990). Effect of recombinant human TNF on human ovarian cancer cell lines. Bollettino della Societa Italiana di Biologia Sperimentale, 66(6), 537-542.

Effect of recombinant human TNF on human ovarian cancer cell lines. / Vigani, A.; Miglietta, L.; Chiara, S.; Repetto, L.; Pichi, E.; Cimoli, G.; Morelli, L.; Poggi, L.; Billi, G.; Parodi, S.

In: Bollettino della Societa Italiana di Biologia Sperimentale, Vol. 66, No. 6, 06.1990, p. 537-542.

Research output: Contribution to journalArticle

Vigani, A, Miglietta, L, Chiara, S, Repetto, L, Pichi, E, Cimoli, G, Morelli, L, Poggi, L, Billi, G & Parodi, S 1990, 'Effect of recombinant human TNF on human ovarian cancer cell lines.', Bollettino della Societa Italiana di Biologia Sperimentale, vol. 66, no. 6, pp. 537-542.
Vigani, A. ; Miglietta, L. ; Chiara, S. ; Repetto, L. ; Pichi, E. ; Cimoli, G. ; Morelli, L. ; Poggi, L. ; Billi, G. ; Parodi, S. / Effect of recombinant human TNF on human ovarian cancer cell lines. In: Bollettino della Societa Italiana di Biologia Sperimentale. 1990 ; Vol. 66, No. 6. pp. 537-542.
@article{324071085a5545e3a3739344e295228d,
title = "Effect of recombinant human TNF on human ovarian cancer cell lines.",
abstract = "Ovarian cancer is the second most common gynecologic malignancy. Standard therapeutic approaches to this disease, surgery followed by chemotherapy, have produced response rates of up to 80{\%}. However, the five-year survival rate remains around 30{\%}. Recently, Tumor Necrosis Factor (TNF) has received attention as either an alternative or an associated agent for chemotherapy of ovarian cancer. TNF is known to have direct cytotoxic and cytostatic effects on a variety of transformed cell lines {"}in vitro{"}. Furthermore, TNF is known to enhance significantly the {"}in vitro{"} effects of a class of chemotherapeutic agents, specifically those targeted at DNA topoisomerase II. In this work we have investigated TNF-induced cytotoxicity in four established human epithelial ovarian cancer cell lines: A-2774; SV-626; SKOV-3 and Pa-1. TNF mediated cytotoxic activity was observed in a range of concentrations between 1 U/ml and 10-3 U/ml. A-2774 and SV-626 were the two most sensitive lines, especially when exposed to high concentrations of TNF.",
author = "A. Vigani and L. Miglietta and S. Chiara and L. Repetto and E. Pichi and G. Cimoli and L. Morelli and L. Poggi and G. Billi and S. Parodi",
year = "1990",
month = "6",
language = "English",
volume = "66",
pages = "537--542",
journal = "Bollettino della Societa Italiana di Biologia Sperimentale",
issn = "0037-8771",
publisher = "Casa Editrice Idelson Gnocchi",
number = "6",

}

TY - JOUR

T1 - Effect of recombinant human TNF on human ovarian cancer cell lines.

AU - Vigani, A.

AU - Miglietta, L.

AU - Chiara, S.

AU - Repetto, L.

AU - Pichi, E.

AU - Cimoli, G.

AU - Morelli, L.

AU - Poggi, L.

AU - Billi, G.

AU - Parodi, S.

PY - 1990/6

Y1 - 1990/6

N2 - Ovarian cancer is the second most common gynecologic malignancy. Standard therapeutic approaches to this disease, surgery followed by chemotherapy, have produced response rates of up to 80%. However, the five-year survival rate remains around 30%. Recently, Tumor Necrosis Factor (TNF) has received attention as either an alternative or an associated agent for chemotherapy of ovarian cancer. TNF is known to have direct cytotoxic and cytostatic effects on a variety of transformed cell lines "in vitro". Furthermore, TNF is known to enhance significantly the "in vitro" effects of a class of chemotherapeutic agents, specifically those targeted at DNA topoisomerase II. In this work we have investigated TNF-induced cytotoxicity in four established human epithelial ovarian cancer cell lines: A-2774; SV-626; SKOV-3 and Pa-1. TNF mediated cytotoxic activity was observed in a range of concentrations between 1 U/ml and 10-3 U/ml. A-2774 and SV-626 were the two most sensitive lines, especially when exposed to high concentrations of TNF.

AB - Ovarian cancer is the second most common gynecologic malignancy. Standard therapeutic approaches to this disease, surgery followed by chemotherapy, have produced response rates of up to 80%. However, the five-year survival rate remains around 30%. Recently, Tumor Necrosis Factor (TNF) has received attention as either an alternative or an associated agent for chemotherapy of ovarian cancer. TNF is known to have direct cytotoxic and cytostatic effects on a variety of transformed cell lines "in vitro". Furthermore, TNF is known to enhance significantly the "in vitro" effects of a class of chemotherapeutic agents, specifically those targeted at DNA topoisomerase II. In this work we have investigated TNF-induced cytotoxicity in four established human epithelial ovarian cancer cell lines: A-2774; SV-626; SKOV-3 and Pa-1. TNF mediated cytotoxic activity was observed in a range of concentrations between 1 U/ml and 10-3 U/ml. A-2774 and SV-626 were the two most sensitive lines, especially when exposed to high concentrations of TNF.

UR - http://www.scopus.com/inward/record.url?scp=0025445728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025445728&partnerID=8YFLogxK

M3 - Article

VL - 66

SP - 537

EP - 542

JO - Bollettino della Societa Italiana di Biologia Sperimentale

JF - Bollettino della Societa Italiana di Biologia Sperimentale

SN - 0037-8771

IS - 6

ER -